WPC
RPRX icon

Wedmont Private Capital’s Royalty Pharma RPRX Stock Holding History

Wedmont Private Capital’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$500K Buy
8,902
+1,345
+18% +$79.3K 0.01% 595
2026
Q2 		$426K Buy
7,557
+492
+7% +$25.6K 0.01% 609
2026
Q1 		$338K Buy
7,065
+356
+5% +$15.6K 0.01% 628
2025
Q4 		$278K Sell
6,709
-84
-1% -$3.2K 0.01% 669
2025
Q3 		$245K Buy
6,793
+331
+5% +$12K 0.01% 679
2025
Q2 		$232K Buy
+6,462
New +$214K 0.01% 672

Other funds holding RPRX

EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
KA
Kearns & Associates Palos Verdes Estates, California $218M AUM 16.36% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Wedmont Private Capital's RPRX Position: Q3 2026 in Review

Wedmont Private Capital increased its Royalty Pharma (RPRX) stake by 18% in Q3 2026, buying an estimated $79.3K and bringing the position to 8,902 shares worth $500K. The position accounts for 0.01% of the portfolio, ranked #595.

Wedmont Private Capital first reported a position in RPRX in Q2 2025 and has held it in 6 quarters since. 21 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Wedmont Private Capital held 8,902 shares of Royalty Pharma worth $500K as of Q3 2026.
  • Wedmont Private Capital bought 1,345 Royalty Pharma shares in Q3 2026, an estimated $79.3K.
  • Royalty Pharma made up 0.01% of Wedmont Private Capital's portfolio in Q3 2026, its #595 holding.
  • Wedmont Private Capital first reported a position in Royalty Pharma in Q2 2025 and has held it in 6 quarters since.
  • 21 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.